Pharmacokinetics of bis(t-butyl-SATE)-AZTMP, a bispivaloylthioethyl prodrug for intracellular delivery of zidovudine monophosphate, in mice

Antiviral Chemistry and Chemotherapy

Volumn 11, Issue 3, 2000, Pages 203-211

  Tan, Xiaolei ^a   Boudinot, F Douglas ^a   Chu, Chung K ^a   Egron, David ^b   Perigaud, Christian ^b   Gosselin, Gilles ^b   Imbach, Jean Louis ^b  

^a UNIVERSITY OF GEORGIA   (United States)

^b UNIVERSITÉ DE MONTPELLIER   (France)

Author keywords

AZT; Bis(t butly SATE) AZTMP; Pharmacokinetics; Prodrug; Zidovudine; Zidovudine monophosphate

Indexed keywords

ABACAVIR; DIDANOSINE; LAMIVUDINE; PRODRUG; S ACYL 2 THIOETHYL; STAVUDINE; UNCLASSIFIED DRUG; ZALCITABINE; ZIDOVUDINE; ZIDOVUDINE MONOPHOSPHATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG DELIVERY SYSTEM; DRUG HALF LIFE; ERYTHROCYTE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0033946524     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632020001100303     Document Type: Article

References (27)

1. Antonelli G, Turriziani O & Verri A (1996) Long term exposure to zidovudine affects in vitro and in vivo the efficiency of phosphorylation of thymidine kinase. AIDS Research and Human Retroviruses 12:223-228.
2. Balzarini J, Herdewijn P & De Clercq E (1988) Differential patterns of intracellular metabolism of 2′,3′-didehydro-2′,3′-dideoxythymidine and 3′-azido-2′,3′-dideoxythymidine, two potent anti-human immunodeficiency virus compounds. Journal of Biological Chemistry 264:6127-6133.
3. Chu CK, Schinazi RF, Ahn MK, Ullas GV & Gu ZP (1989) Structure-activity relationships of pyrimidine nucleosides as antiviral agents for human immunodeficiency virus type I in peripheral blood mononuclear cells. Journal of Medicinal Chemistry 32:612-617.
4. Doshi KJ, Gallo JM, Boudinot FD, Schinazi RF & Chu CK (1989) Comparative pharmacokinetics of 3′-azido-3′-deoxythymidine (AZT) and 3′-azido-2′,3′-dideoxyuridine (AZdU) in mice. Drug Metabolism and Disposition 17:590-594.
5. Gao W-Y, Agbaria R, Driscoll JS & Mitsuya H (1994) Divergent anti-human immunodeficiency virus activity and anabolic phosphorylation of 2′,3′-dideoxynucleoside analogs in resting and activated human cells. Journal of Biological Chemistry 269:12633-12638.
6. Gao W-Y, Shirasaka Y, Johns DG, Broder S & Mitsuya H (1993) Differential phosphorylation of azidothymidine, dideoxycytidine, and dideoxyinosine in resting and activated peripheral blood mononuclear cells. Journal of Clinical Investigation 91:2326-2333.
7. Haase AT, Henry K, Zupancic M, Sedgewick G, Faust RA, Melroe H, Cavert W, Gebhard K, Staskus K, Zhang Z-Q, Dailey PJ, Balfour HH Jr, Erice A & Perelson AS (1996) Quantitative image analysis of HIV-1 infection in lymphoid tissues. Science 274:985-989.
8. Jaobsson B, Britton S, He Q, Karlsson A & Eriksson S (1995) Decreased thymidine kinases levels in peripheral blood cells from HIV-seropositive individuals: implication for zidovudine metabolism. AIDS Research and Human Retroviruses 11:805-811.
9. Lefebvre I, Perigaud C, Pompon A, Aubertin A-M, Girardet J-L, Kirn A, Gosselin G & Imbach J-L (1995) Mononucleoside phosphotriester derivatives with S-acyl-2-thioethyl bioconversible phosphate-protecting groups: intracellular delivery of 3′-azido-2′,3′-dideoxythymidine 5′-monophosphate. Journal of Medicinal Chemistry 38:3941-3950.
10. Manouilov KK, White CA, Boudinct FD, Fedorov II & Chu CK (1995) Lymphatic distribution of 3′-azido-3′-deoxythymidine and 3′-azido-2′3′-dideoxyuridine in mice. Drug Metabolism and Disposition 23:655-658.
11. McGuigan C, Pathirana RN, Balzarini J & De Clercq E (1993) Intracellular delivery of bioactive AZT nucleotides by aryl phosphate derivatives of AZT. Journal of Medicinal Chemistry 36:1048-1052.
12. Meier C, Knispel T, De Clercq & Balzarini J (1999a) cycloSal-pronucleotides of 2′,3′-dideoxyadenosine and 2′,3′-dideoxy-2′,3′-didehydroadenosine: synthesis and antiviral evaluation of a highly efficient nucleotide delivery system. Journal of Medicinal Chemistry 42:1604-1614.
13. Meier C, Knispel T, Marquez VE, Siddiqui, MA, De Clercq E & Balzarini J (1999b) cycloSal-pronucleotides of 2′-fluoro-ara- and 2′-fluoro-ribo-2′,3′-dideoxyadenosine as a strategy to bypass a metabolic blockade. Journal of Medicinal Chemistry 42:1615-1624.
14. National Research Council, Institute of Laboratory Animal Resources (1996) Guide For the Care and Use of Laboratory Animals. Washington, DC: National Academy Press.
15. Patel BA, Chu CK & Boudinot FD (1989) Pharmacokinetics and saturable renal tubular secretion of zidovudine in rats. Journal of Pharmaceutical Science 78:530-534.
16. Perigaud C, Aubertin A-M, Benzaria S, Pelicano H, Girardet J-L, Maury G, Gosselin G, Kirn A & Imbach J-L (1994) Equal inhibition of the replication of human immunodeficiency virus in human T-cell culture by ddA bis(SATE)phophotriester and 3′-azido-2′,3′-dideoxythymidine. Biochemical Pharmacology 48:11-14.
17. Perigaud C, Girardet J-L, Lefebvre I, Xie M-Y, Aubertin A-M, Kirn A, Gosselin G, Imbach J-L & Sommadossi J-P (1996) Comparison of cytotoxicity of mononucleoside phosphotriester derivatives bearing biolabile phosphate protecting groups in normal human bone marrow progenitors cell. Antiviral Chemistry and Chemotherapy 7:338-345.
18. Perno CF, Yarchoan R, Cooney DA, Hartman NR, Webb DS, Hao Z, Mitsuya H, Johns DG & Broder S (1988) Inhibition of human immunodeficiency virus (HIV-1/HTLV-IIIBa-1) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidme and related 2′,3′-dideoxynucleosides. Journal of Experimental Medicine 168: 111-1125.
19. Price RW (1995) Management of AIDS dementia complex and HIV-1 infection of nervous system. AIDS 9 (Suppl. A):221-236.
20. Puech F, Gosselin G, Lefebvre I, Pompon A, Aubertin M, Kirn A & Imbach J-L (1993) Intracellular delivery of nucleoside monophosphates through a reductase-mediated activation process. Antiviral Research 22:155-174.
21. Rocci ML & Jusko WJ (1983) LAGRAN program for area and moments in pharmacokinetic analysis. Computer Programs in Biomedicine 16: 203-216.
22. Sastry KJ, Nethete PN, Khan S, Plunkett W, Arlinghaus RB & Farquhar D (1992) A new strategy for the chemotherapy of acquired immunodeficiency syndrome: membrane permeable dideoxyuridine monophosphate analogues as potent inhibitors of human immunodeficiency virus infection. Molecular Pharmacology 41:441-445.
23. Shirasaka T, Chokekijchai S, Yamada A, Gosselin G, Imbach J-L & Mitsuya H (1995) Comparative analysis of anti-human immunodeficiency virus type 1 activities of dideoxynucleoside analogs in resting and activated peripheral blood mononuclear cells. Antimicrobial Agents Chemotherapy 39:2555-2559.
24. Tan X & Boudinot FD (2000) Simultaneous determination of zidovudine (AZT) and its monophosphate (AZTMP) in mouse plasma and peripheral red blood cells by high performance liquid chromatography. Journal of Chromatography B: Biomedical Aplications 340:281-287.
25. Thumann-Schweitzer C, Gosselin G, Perigaud C, Benzaria S, Girardet J-L, Lefebvre I, Imbach J-L, Kirn A & Aubertin A-M (1996) Anti-human immunodeficiency virus type 1 activities of dideoxynucleoside phosphotriester derivatives in primary monocytes/macrophages. Research in Virology 147:155-163.
26. Valette G, Pompon A, Girardet J-L, Cappellacci L, Franchetti P, Grifantini M, Colla PL, Loi AG, Perigaud C, Gosselin G & Imbach J-L (1996) Decomposition pathways and in vitro HIV inhibitory effects of isoddA pronucleostides: toward a rational approach for intracellular delivery of nucleoside 5′-monophosphates. Journal of Medicinal Chemistry 39:1981-1990.
27. Yuan J (1993) Estimation of variance for AUC in animal studies. Journal of Pharmaceutical Science 82:761-763.